During the past decade, Prisma Health Cancer Institute - Seneca conducted 181 clinical trials. In the 10-year time frame, 181 clinical trials started and 134 clinical trials were completed, i.e. on average, 74% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 86 clinical trials were completed. i.e. 148.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Seneca" #1 sponsor was "National Cancer Institute (NCI)" with 103 trials, followed by "SWOG Cancer Research Network" with 58 trials sponsored, "Alliance for Clinical Trials in Oncology" with 56 trials sponsored, "NRG Oncology" with 20 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Seneca" #1 collaborator was "National Cancer Institute (NCI)" with 186 trials as a collaborator, "NRG Oncology" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Seneca" are "Breast Cancer" (20 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Colorectal Cancer" (8 trials), "Lung Cancer" (8 trials) and "Stage IV Lung Cancer AJCC v8" (8 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Seneca" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Seneca" are "Drug" (230 trials), "Other" (196 trials), "Biological" (95 trials), "Procedure" (61 trials) and "Radiation" (57 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (72 trials), "Questionnaire Administration" (53 trials), "Cisplatin" (29 trials) and "Paclitaxel" (28 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Seneca" are 238 trials for "All" genders, 54 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Seneca". undefined are not yet recruiting, 61 are recruiting, 134 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in Prisma Health Cancer Institute - Seneca, 6 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Seneca, 6 "Phase 1" clinical trials were conducted, 124 "Phase 2" clinical trials and 160 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 19 trials that are defined as “Not Applicable".